| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed for patients aged 6 and up; Cotempla XR-ODT, tailored for individuals between 6 and 17 years old; and Adzenys ER, an oral liquid formulation also for those 6 years and older. Additionally, the company …
Over the last 12 months, insiders at Aytu BioPharma, Inc. have bought $0 and sold $0 worth of Aytu BioPharma, Inc. stock.
On average, over the past 5 years, insiders at Aytu BioPharma, Inc. have bought $157,923 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 66,666 shares for transaction amount of $99,999 was made by Disbrow Joshua R. (Chief Executive Officer) on 2025‑06‑09.
| 2025-06-09 | Disbrow Joshua R. | Chief Executive Officer | 66,666 0.7681% | $1.50 | $99,999 | +10.43% | ||
| 2025-06-09 | Disbrow Jarrett | Chief Business Officer | 16,666 0.192% | $1.50 | $24,999 | +10.43% | ||
| 2025-02-28 | Disbrow Joshua R. | Chief Executive Officer | 15,000 0.245% | $1.30 | $19,500 | +70.54% | ||
| 2023-06-16 | PYSZCZYMUKA GREG | Chief Commerical Officer | 12,000 0.3307% | $1.87 | $22,428 | +53.30% | ||
| 2023-06-14 | Disbrow Joshua R. | Chief Executive Officer | 14,000 0.3999% | $1.86 | $26,079 | +59.14% | ||
| 2022-12-19 | Disbrow Joshua R. | Chief Executive Officer | 112,371 0.1842% | $0.22 | $25,048 | -47.73% | ||
| 2022-12-19 | PYSZCZYMUKA GREG | Chief Commercial Officer | 100,000 0.18% | $0.24 | $24,480 | -47.73% | ||
| 2022-11-18 | Disbrow Joshua R. | Chief Executive Officer | 222,000 0.3705% | $0.24 | $52,614 | -50.00% | ||
| 2022-11-18 | Oki Mark K | Chief Financial Officer | 90,000 0.1458% | $0.23 | $20,700 | -50.00% | ||
| 2020-12-11 | ARMISTICE CAPITAL, LLC | director | 1.33M 9.5911% | $6.00 | $8M | -17.04% | ||
| 2020-04-27 | Sale | ARMISTICE CAPITAL, LLC | director | 5.11M 4.0608% | $1.82 | $9.3M | -49.75% | |
| 2020-04-15 | Sale | Cerecor Inc. | 10 percent owner | 92,777 0.082% | $1.55 | $144,092 | -33.23% | |
| 2020-03-10 | Sale | ARMISTICE CAPITAL, LLC | director | 22.03M 43.1464% | $1.42 | $31.2M | -41.46% | |
| 2019-12-20 | ARMISTICE CAPITAL, LLC | 26,000 0.1525% | $0.88 | $22,880 | +39.53% | |||
| 2019-12-19 | ARMISTICE CAPITAL, LLC | 52,788 0.3082% | $0.85 | $44,870 | +44.58% | |||
| 2019-12-19 | Disbrow Joshua R. | 55,000 0.3354% | $0.89 | $48,824 | +44.58% | |||
| 2018-12-21 | Sale | Green David A | Chief Financial Officer | 3,330 0.053% | $0.81 | $2,711 | +74.68% | |
| 2018-03-06 | Disbrow Joshua R. | Chief Executive Officer | 226,105 2.044% | $0.45 | $101,747 | -49.76% | ||
| 2018-03-06 | Disbrow Jarrett | Chief Operating Officer | 226,105 2.044% | $0.45 | $101,747 | -49.76% | ||
| 2018-03-06 | Green David A | Chief Financial Officer | 66,600 0.6021% | $0.45 | $29,970 | -49.76% |
| DOCKERY CARL | director | 5047591 46.45% | $9.74M | 1 | 0 | |
| ARMISTICE CAPITAL, LLC | director | 1333334 12.2699% | $2.57M | 3 | 2 | <0.0001% |
| Gould Gregory A | Chief Financial Officer | 273565 2.5175% | $527,980.45 | 1 | 0 | |
| Green David A | Chief Financial Officer | 266250 2.4501% | $513,862.50 | 1 | 1 | |
| Oki Mark K | Chief Financial Officer | 190000 1.7485% | $366,700.00 | 1 | 0 | <0.0001% |
| Disbrow Joshua R. | Chief Executive Officer | 153257 1.4103% | $295,786.01 | 10 | 0 | +8.48% |
| Cantrell Gary | director | 98333 0.9049% | $189,782.69 | 1 | 0 | |
| Disbrow Jarrett | Chief Business Officer | 29462 0.2711% | $56,861.66 | 5 | 0 | +10.43% |
| PYSZCZYMUKA GREG | Chief Commerical Officer | 21935 0.2019% | $42,334.55 | 2 | 0 | +2.78% |
$2,101,005 | 2135 | -11.51% | $64.58M | |
$131,310,609 | 62 | 26.99% | $107.44M | |
$2,767,882 | 51 | 8.70% | $24.78M | |
$30,221,759 | 51 | 0.50% | $20.6M | |
$33,884,330 | 45 | 12.56% | $223.45M |
| Increased Positions | 18 | +52.94% | 295,140 | +8.24% |
| Decreased Positions | 9 | -26.47% | 104,002 | -2.9% |
| New Positions | 9 | New | 164,986 | New |
| Sold Out Positions | 3 | Sold Out | 17,443 | Sold Out |
| Total Postitions | 43 | +26.47% | 4M | +5.34% |
| Nantahala Capital Management, Llc | $3,010.00 | 10.87% | 1.09M | 0 | 0% | 2025-09-30 |
| Stonepine Capital Management, Llc | $2,470.00 | 8.92% | 891,855 | +79,179 | +9.74% | 2025-09-30 |
| Awm Investment Company, Inc. | $1,716.00 | 6.2% | 619,574 | -300 | -0.05% | 2025-09-30 |
| Vanguard Group Inc | $772.00 | 2.79% | 278,583 | +250,695 | +898.93% | 2025-09-30 |
| Diadema Partners Lp | $755.00 | 2.73% | 272,670 | +272,670 | New | 2025-09-30 |
| Renaissance Technologies Llc | $263.00 | 0.95% | 95,123 | +5,210 | +5.79% | 2025-09-30 |
| Geode Capital Management, Llc | $197.00 | 0.71% | 71,006 | +17,137 | +31.81% | 2025-09-30 |
| Two Sigma Investments, Lp | $190.00 | 0.69% | 68,736 | +33,701 | +96.19% | 2025-09-30 |
| Persistent Asset Partners Ltd | $173.00 | 0.63% | 62,452 | +62,452 | New | 2025-09-30 |
| Two Sigma Advisers, Lp | $110.00 | 0.4% | 39,800 | +39,800 | New | 2025-09-30 |